search
Back to results

COVID-19 Messaging for Vaccination

Primary Purpose

Vaccination Refusal, COVID-19 Pandemic

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Doctor Videos
Sharing Videos
Sharing Videos (Influencers)
Vaccine Ambassador
Video framing
Video order
Sponsored by
Massachusetts Institute of Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Vaccination Refusal focused on measuring Covid-19 Vaccine, Social Media

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Facebook user
  • Over 18 years old
  • In a geographic area targeted by the study

Exclusion Criteria:

-

Sites / Locations

  • Massachusetts Institute of Technology

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Control

Treatment 1: Direct

Treatment 2: Friends

Treatment 3: Gossips

Arm Description

No intervention in this arm; the study team will examine publicly available county- and zip code-level outcomes in this group.

Facebook users in the area receive ads which include videos of health professionals telling them to get vaccinated. The health professionals answer common questions about Covid-19 vaccines (e.g. are they safe / are they free).

Facebook users in the area receive ads which include videos of health professionals encouraging them to help their friends to get vaccinated. There is also a link in the ad to a website build by the study team. This website hosts videos which answer common questions about vaccination (the same videos which are directly served to Facebook users in Treatment 1).

Facebook users in the area receive ads which include videos of health professionals encouraging them to nominate their most influential friends to help their friends get vaccinated. The difference from Treatment 2 is that the health professionals call on Facebook users to get their most influential friends to do the convincing about the vaccine. There is also a link in the ad to a website built by the study team. This website hosts videos which answer common questions about vaccination (the same videos that are directly served to Facebook users in Treatment 1).

Outcomes

Primary Outcome Measures

Changes in County-Level Covid-19 Vaccination Measured by Inverse Hyperbolic Sine
County-level Covid-19 vaccination rates were analysed using publicly available data. The number of new vaccinations in each county was transformed using the inverse hyperbolic sine because the underlying vaccination count data were right-skewed and included zeros. Larger numbers are considered better in the context of the study (more people vaccinated).

Secondary Outcome Measures

Full Information

First Posted
October 21, 2021
Last Updated
August 23, 2023
Sponsor
Massachusetts Institute of Technology
Collaborators
Facebook, Inc., Code3, Stanford University, Harvard University, Yale University, Johns Hopkins University, Massachusetts General Hospital, Ludwig-Maximilians - University of Munich, National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT05182554
Brief Title
COVID-19 Messaging for Vaccination
Official Title
Increasing the Effectiveness and Diffusion of COVID-19 Messaging for Vaccination
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
December 22, 2021 (Actual)
Primary Completion Date
January 27, 2022 (Actual)
Study Completion Date
January 27, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Massachusetts Institute of Technology
Collaborators
Facebook, Inc., Code3, Stanford University, Harvard University, Yale University, Johns Hopkins University, Massachusetts General Hospital, Ludwig-Maximilians - University of Munich, National Institutes of Health (NIH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will distribute videos of health professionals encouraging Covid-19 vaccination to a large sample of Facebook users, and will test the most effective ways to maximize diffusion of this vaccine-related content to increase vaccination rates. The study sample will be U.S. states where vaccination rates remained low in fall 2021. The experimental design is an RCT with 4 groups, randomized at the county level: 1) a control group which receives no intervention, 2) a treatment group in which Facebook users receive ads which include videos of health professionals telling them to get vaccinated, 3) a treatment group in which Facebook users receive ads which include videos of health professionals encouraging them to help their friends to get vaccinated, and 4) a treatment group in which Facebook users receive ads which include videos of health professionals encouraging them to get their most influential friends to help their friends get vaccinated. In treatments 3 and 4, participants will have the option to sign up to be a "vaccine ambassador," in which case they will get notifications when the study team posts new vaccine-related content, and will receive reminders about encouraging their friends to be vaccinated. The vaccine ambassadors will also be entered into a lottery to win prizes. The study team is building a website to host the videos of health professionals which answer common questions about Covid-19 vaccination. The investigators will measure engagement with the vaccine-related content as well as assess effects on vaccination rates at the county level.
Detailed Description
The study will have three treatment arms and a control group. Each of the treatments will be randomized at the county level and will be initiated through a Facebook ad campaign. Experimental Sample: The experimental sample includes all states where less than 60% of the total population had received a first dose of Covid-19 vaccine by October 21, 2021. There are 1402 counties in the 19 states satisfying those criteria (Alabama, Alaska, Arkansas, Georgia, Idaho, Iowa, Indiana, Louisiana, Michigan, Mississippi, Missouri, Montana, North Dakota, Ohio, Oklahoma, South Carolina, Tennessee, West Virginia, Wyoming). Excluding the five counties with missing data, there are 1,397 counties in the experiment, of which there are 468 counties in the control group, 310 counties in T1 ("direct" messaging) treatment, 309 counties in T2 ("friends" messaging), and 310 counties in T3 ("gossips" messaging). The following procedures will be used: Treatment Group 1 ("Direct" messaging): The investigators will conduct a Facebook ad campaign to show content about COVID-19 vaccination to a large number of Facebook users. Facebook will allocate ad credits across users in treatment areas. The ads will be displayed twice per week for 3-4 weeks. Like for any Facebook ad, individuals can choose to whether or not to watch the video and can close the ad at any time. If individuals wish, they can also share any of the content with others. The videos shown in the ads will be hosted on our project Facebook page "Doctors for Coronavirus Prevention." As in previous projects by the investigators, a health professional (normally wearing a white coat or scrubs) will read very short scripts directly onto the camera (see eg. https://www.facebook.com/doctors4covidprevention/posts/104965558099200 for an example). Treatment Group 2 ("Friends" messaging): For this group, the Facebook ad campaign will recruit individuals to become "vaccine ambassadors" to help spread the word about vaccination to their friends, families and communities. Recruitment ads will be disseminated in a similar manner to the content in T1. Individuals will be able to share the ad with others. Individuals interested in learning more can click through a link in the ad to the vaccine ambassador webpage. Participants can consume or share any of the information on the webpage. Interested individuals can also enroll formally as vaccine ambassadors. They can share their contact information with the study to a) be entered into prize lotteries, b) receive reminders to share content with others, c) be contacted in the future for possible follow-up surveys. They will be asked to give their informed consent at this time and will be screened based on whether they live in a treated county and whether they are 18 years or older. Treatment Group 3 ("Gossips" messaging): This treatment looks the same as Treatment Group 2, except the recruitment ads will differ slightly. If the individual clicks through to learn more about vaccine ambassadors, they will also be reminded to share the invitation with people they know who are often the source of important news or information. Control: individuals in these counties will receive no intervention and will never be contacted by members of the study team. Treatment and control status at the county level will be merged with aggregated and de-identified datasets to measure COVID vaccinations, COVID symptoms, and cases, and engagement with the vaccine ambassador content. The study team will create a series of websites with materials that the vaccine ambassadors can share with friends, family and others in their communities. This same content will be disseminated through sponsored Facebook ads in T1. On the website, the framing of the vaccine-related videos with either a "fact" or "myth" frame will be randomized. The purpose is to study which framing is more effective at engaging users.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vaccination Refusal, COVID-19 Pandemic
Keywords
Covid-19 Vaccine, Social Media

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
There are four arms in the study which geographic areas are assigned to in parallel. The geographic areas in the three treatment arms will receive a Facebook ad campaign over the same time period to one another.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
No intervention in this arm; the study team will examine publicly available county- and zip code-level outcomes in this group.
Arm Title
Treatment 1: Direct
Arm Type
Experimental
Arm Description
Facebook users in the area receive ads which include videos of health professionals telling them to get vaccinated. The health professionals answer common questions about Covid-19 vaccines (e.g. are they safe / are they free).
Arm Title
Treatment 2: Friends
Arm Type
Experimental
Arm Description
Facebook users in the area receive ads which include videos of health professionals encouraging them to help their friends to get vaccinated. There is also a link in the ad to a website build by the study team. This website hosts videos which answer common questions about vaccination (the same videos which are directly served to Facebook users in Treatment 1).
Arm Title
Treatment 3: Gossips
Arm Type
Experimental
Arm Description
Facebook users in the area receive ads which include videos of health professionals encouraging them to nominate their most influential friends to help their friends get vaccinated. The difference from Treatment 2 is that the health professionals call on Facebook users to get their most influential friends to do the convincing about the vaccine. There is also a link in the ad to a website built by the study team. This website hosts videos which answer common questions about vaccination (the same videos that are directly served to Facebook users in Treatment 1).
Intervention Type
Behavioral
Intervention Name(s)
Doctor Videos
Intervention Description
Receive ads on Facebook or through our website with videos in which health professionals tell people to get the Covid-19 vaccine. The health professionals answer common questions about the Covid-19 vaccine, such as how mRNA vaccines work, and what types of side effects to expect.
Intervention Type
Behavioral
Intervention Name(s)
Sharing Videos
Intervention Description
Receive ads on Facebook with videos in which health professionals tell people to encourage their unvaccinated friends to get the Covid-19 vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Sharing Videos (Influencers)
Intervention Description
Receive ads on Facebook with videos in which health professionals tell people to get their most influential friends to encourage their unvaccinated friends to get the Covid-19 vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Vaccine Ambassador
Intervention Description
Adults in participating geographic areas can sign up to be a "vaccine ambassador" on a website that the study team has built. The study team will send updates to vaccine ambassadors when new content has been posted to the website (e.g. a new video) and/or to remind the vaccine ambassadors to encourage their friends to get vaccinated. The study team will incentivize vaccine ambassadors by entering participating ambassadors into a lottery for a prize.
Intervention Type
Behavioral
Intervention Name(s)
Video framing
Intervention Description
The same videos will be displayed using two different frames: a "myth" frame and a "fact" frame. Visitors to the vaccine content website will randomly receive one framing of each video.
Intervention Type
Behavioral
Intervention Name(s)
Video order
Intervention Description
The order in which videos appear on the vaccine content website will be randomized.
Primary Outcome Measure Information:
Title
Changes in County-Level Covid-19 Vaccination Measured by Inverse Hyperbolic Sine
Description
County-level Covid-19 vaccination rates were analysed using publicly available data. The number of new vaccinations in each county was transformed using the inverse hyperbolic sine because the underlying vaccination count data were right-skewed and included zeros. Larger numbers are considered better in the context of the study (more people vaccinated).
Time Frame
During intervention (6 weeks) and after intervention (3 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Facebook user Over 18 years old In a geographic area targeted by the study Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Esther Duflo, PhD
Organizational Affiliation
Massachusetts Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ben Olken, PhD
Organizational Affiliation
Massachusetts Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Abhijit Banerjee, PhD
Organizational Affiliation
Massachusetts Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marcella Alsan, MD, PhD
Organizational Affiliation
Harvard Kennedy School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Arun Chandrasekhar, PhD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Emily Breza, PhD
Organizational Affiliation
Harvard University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Paul Goldsmith-Pinkham, PhD
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Emily Hoppe, PhD Student
Organizational Affiliation
Johns Hopkins School of Nursing
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pierre-Luc Vautrey, PhD Student
Organizational Affiliation
Massachusetts Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lisa Ho, PhD Student
Organizational Affiliation
Massachusetts Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lucy Ogbu-Nwobodo, MD
Organizational Affiliation
MGH/McLean Harvard Psychiatry Program
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Erica Warner, ScD, MPH
Organizational Affiliation
Harvard Medical School & Massachusetts General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carlos Torres, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Fatima Stanford, MD, MPH, MPA
Organizational Affiliation
Harvard Medical School & Massachusetts General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sarah Eichmeyer, PhD
Organizational Affiliation
Ludwig-Maximilians - University of Munich
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts Institute of Technology
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02139
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The investigators do not plan to share any individual participant data. The only individual participant data that the study will collect will be contact information through the "vaccine ambassador" program. "Vaccine ambassadors" are adults living in geographic areas assigned to Treatment 2 or Treatment 3 who have signed up on the study website to receive updates and reminders about vaccination-related content. However, the study team does not plan on collecting any information about the behavior of vaccine ambassadors, and so do not plan to share any of their data (which will just consisting of contact information) with other researchers.

Learn more about this trial

COVID-19 Messaging for Vaccination

We'll reach out to this number within 24 hrs